Reports

Industry Research Reports

Global 8-Hydroxyquinoline Market Outlook, In‑Depth Analysis & Forecast to 2031

Global 8-Hydroxyquinoline Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 182 Pages

Report ld: 5286216

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global 8-Hydroxyquinoline market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

From a downstream perspective, Medicine accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

8-Hydroxyquinoline leading manufacturers including 3M Company (US), ABC Compounding Company (US), Ecolab (US), DuPont (US), Henkel (DE), Kao Corporation (JP), Medical Chemical Corporation (US), Metrex Research (US), Prestige Brands (US), P&G (US), etc., dominate supply; the top five capture approximately % of global revenue, with 3M Company (US) leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global 8-Hydroxyquinoline market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • 3M Company (US)
  • ABC Compounding Company (US)
  • Ecolab (US)
  • DuPont (US)
  • Henkel (DE)
  • Kao Corporation (JP)
  • Medical Chemical Corporation (US)
  • Metrex Research (US)
  • Prestige Brands (US)
  • P&G (US)
  • RB Plc. (UK)
  • SC Johnson & Son (US)
  • Sealed Air Corporation (US)
  • Diversey (US)
  • Steris (US)
  • The Clorox Company (US)
  • Unilever (UK)
  • Zep (US)
  • Zhejiang Huangyan Wanfeng(CN)
  • Suzhou Best(CN)
  • Anshan Beida(CN)
  • Jiangxi Sanyuan(CN)
  • Yixing Hongbo(CN)
  • Taixing Shenfeng(CN)

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Below 98%
  • 98-99%
  • 99-99.5%
  • Above 99.5%

Segment by Application

  • Medicine
  • Agriculture
  • Scientific
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the 8-Hydroxyquinoline study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

marn_i1

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

marn_i1

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

marn_i1

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

marn_i1

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

marn_i1

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

marn_i1

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

marn_i1

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to 8-Hydroxyquinoline: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global 8-Hydroxyquinoline Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Below 98%

1.2.3 98-99%

1.2.4 99-99.5%

1.2.5 Above 99.5%

1.3 Market Segmentation by Application

1.3.1 Global 8-Hydroxyquinoline Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Medicine

1.3.3 Agriculture

1.3.4 Scientific

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global 8-Hydroxyquinoline Revenue Estimates and Forecasts 2020-2031

2.2 Global 8-Hydroxyquinoline Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global 8-Hydroxyquinoline Sales Estimates and Forecasts 2020-2031

2.4 Global 8-Hydroxyquinoline Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

muLu

3 Global Production Analysis

3.1 Global 8-Hydroxyquinoline Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

muLu

4 Competition by Manufacturers

4.1 Global 8-Hydroxyquinoline Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global 8-Hydroxyquinoline Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Below 98% Market Size by Manufacturers

4.5.2 98-99% Market Size by Manufacturers

4.5.3 99-99.5% Market Size by Manufacturers

4.5.4 Above 99.5% Market Size by Manufacturers

4.6 Global 8-Hydroxyquinoline Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

muLu

5 Global Product Segmentation Analysis

5.1 Global 8-Hydroxyquinoline Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global 8-Hydroxyquinoline Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

muLu

6 Global Downstream Application Analysis

6.1 Global 8-Hydroxyquinoline Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global 8-Hydroxyquinoline Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

muLu

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America 8-Hydroxyquinoline Sales and Revenue by Type (2020-2031)

7.4 North America 8-Hydroxyquinoline Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America 8-Hydroxyquinoline Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

muLu

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe 8-Hydroxyquinoline Sales and Revenue by Type (2020-2031)

8.4 Europe 8-Hydroxyquinoline Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe 8-Hydroxyquinoline Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

muLu

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific 8-Hydroxyquinoline Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific 8-Hydroxyquinoline Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific 8-Hydroxyquinoline Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

muLu

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America 8-Hydroxyquinoline Sales and Revenue by Type (2020-2031)

10.4 Central and South America 8-Hydroxyquinoline Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America 8-Hydroxyquinoline Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

muLu

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa 8-Hydroxyquinoline Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa 8-Hydroxyquinoline Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa 8-Hydroxyquinoline Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

muLu

12 Corporate Profile

12.1 3M Company (US)

12.1.1 3M Company (US) Corporation Information

12.1.2 3M Company (US) Business Overview

12.1.3 3M Company (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.1.4 3M Company (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 3M Company (US) 8-Hydroxyquinoline Sales by Product in 2024

12.1.6 3M Company (US) 8-Hydroxyquinoline Sales by Application in 2024

12.1.7 3M Company (US) 8-Hydroxyquinoline Sales by Geographic Area in 2024

12.1.8 3M Company (US) 8-Hydroxyquinoline SWOT Analysis

12.1.9 3M Company (US) Recent Developments

12.2 ABC Compounding Company (US)

12.2.1 ABC Compounding Company (US) Corporation Information

12.2.2 ABC Compounding Company (US) Business Overview

12.2.3 ABC Compounding Company (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.2.4 ABC Compounding Company (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 ABC Compounding Company (US) 8-Hydroxyquinoline Sales by Product in 2024

12.2.6 ABC Compounding Company (US) 8-Hydroxyquinoline Sales by Application in 2024

12.2.7 ABC Compounding Company (US) 8-Hydroxyquinoline Sales by Geographic Area in 2024

12.2.8 ABC Compounding Company (US) 8-Hydroxyquinoline SWOT Analysis

12.2.9 ABC Compounding Company (US) Recent Developments

12.3 Ecolab (US)

12.3.1 Ecolab (US) Corporation Information

12.3.2 Ecolab (US) Business Overview

12.3.3 Ecolab (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.3.4 Ecolab (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Ecolab (US) 8-Hydroxyquinoline Sales by Product in 2024

12.3.6 Ecolab (US) 8-Hydroxyquinoline Sales by Application in 2024

12.3.7 Ecolab (US) 8-Hydroxyquinoline Sales by Geographic Area in 2024

12.3.8 Ecolab (US) 8-Hydroxyquinoline SWOT Analysis

12.3.9 Ecolab (US) Recent Developments

12.4 DuPont (US)

12.4.1 DuPont (US) Corporation Information

12.4.2 DuPont (US) Business Overview

12.4.3 DuPont (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.4.4 DuPont (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 DuPont (US) 8-Hydroxyquinoline Sales by Product in 2024

12.4.6 DuPont (US) 8-Hydroxyquinoline Sales by Application in 2024

12.4.7 DuPont (US) 8-Hydroxyquinoline Sales by Geographic Area in 2024

12.4.8 DuPont (US) 8-Hydroxyquinoline SWOT Analysis

12.4.9 DuPont (US) Recent Developments

12.5 Henkel (DE)

12.5.1 Henkel (DE) Corporation Information

12.5.2 Henkel (DE) Business Overview

12.5.3 Henkel (DE) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.5.4 Henkel (DE) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Henkel (DE) 8-Hydroxyquinoline Sales by Product in 2024

12.5.6 Henkel (DE) 8-Hydroxyquinoline Sales by Application in 2024

12.5.7 Henkel (DE) 8-Hydroxyquinoline Sales by Geographic Area in 2024

12.5.8 Henkel (DE) 8-Hydroxyquinoline SWOT Analysis

12.5.9 Henkel (DE) Recent Developments

12.6 Kao Corporation (JP)

12.6.1 Kao Corporation (JP) Corporation Information

12.6.2 Kao Corporation (JP) Business Overview

12.6.3 Kao Corporation (JP) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.6.4 Kao Corporation (JP) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Kao Corporation (JP) Recent Developments

12.7 Medical Chemical Corporation (US)

12.7.1 Medical Chemical Corporation (US) Corporation Information

12.7.2 Medical Chemical Corporation (US) Business Overview

12.7.3 Medical Chemical Corporation (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.7.4 Medical Chemical Corporation (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Medical Chemical Corporation (US) Recent Developments

12.8 Metrex Research (US)

12.8.1 Metrex Research (US) Corporation Information

12.8.2 Metrex Research (US) Business Overview

12.8.3 Metrex Research (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.8.4 Metrex Research (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Metrex Research (US) Recent Developments

12.9 Prestige Brands (US)

12.9.1 Prestige Brands (US) Corporation Information

12.9.2 Prestige Brands (US) Business Overview

12.9.3 Prestige Brands (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.9.4 Prestige Brands (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Prestige Brands (US) Recent Developments

12.10 P&G (US)

12.10.1 P&G (US) Corporation Information

12.10.2 P&G (US) Business Overview

12.10.3 P&G (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.10.4 P&G (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 P&G (US) Recent Developments

12.11 RB Plc. (UK)

12.11.1 RB Plc. (UK) Corporation Information

12.11.2 RB Plc. (UK) Business Overview

12.11.3 RB Plc. (UK) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.11.4 RB Plc. (UK) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 RB Plc. (UK) Recent Developments

12.12 SC Johnson & Son (US)

12.12.1 SC Johnson & Son (US) Corporation Information

12.12.2 SC Johnson & Son (US) Business Overview

12.12.3 SC Johnson & Son (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.12.4 SC Johnson & Son (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 SC Johnson & Son (US) Recent Developments

12.13 Sealed Air Corporation (US)

12.13.1 Sealed Air Corporation (US) Corporation Information

12.13.2 Sealed Air Corporation (US) Business Overview

12.13.3 Sealed Air Corporation (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.13.4 Sealed Air Corporation (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Sealed Air Corporation (US) Recent Developments

12.14 Diversey (US)

12.14.1 Diversey (US) Corporation Information

12.14.2 Diversey (US) Business Overview

12.14.3 Diversey (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.14.4 Diversey (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.14.5 Diversey (US) Recent Developments

12.15 Steris (US)

12.15.1 Steris (US) Corporation Information

12.15.2 Steris (US) Business Overview

12.15.3 Steris (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.15.4 Steris (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.15.5 Steris (US) Recent Developments

12.16 The Clorox Company (US)

12.16.1 The Clorox Company (US) Corporation Information

12.16.2 The Clorox Company (US) Business Overview

12.16.3 The Clorox Company (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.16.4 The Clorox Company (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.16.5 The Clorox Company (US) Recent Developments

12.17 Unilever (UK)

12.17.1 Unilever (UK) Corporation Information

12.17.2 Unilever (UK) Business Overview

12.17.3 Unilever (UK) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.17.4 Unilever (UK) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.17.5 Unilever (UK) Recent Developments

12.18 Zep (US)

12.18.1 Zep (US) Corporation Information

12.18.2 Zep (US) Business Overview

12.18.3 Zep (US) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.18.4 Zep (US) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.18.5 Zep (US) Recent Developments

12.19 Zhejiang Huangyan Wanfeng(CN)

12.19.1 Zhejiang Huangyan Wanfeng(CN) Corporation Information

12.19.2 Zhejiang Huangyan Wanfeng(CN) Business Overview

12.19.3 Zhejiang Huangyan Wanfeng(CN) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.19.4 Zhejiang Huangyan Wanfeng(CN) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.19.5 Zhejiang Huangyan Wanfeng(CN) Recent Developments

12.20 Suzhou Best(CN)

12.20.1 Suzhou Best(CN) Corporation Information

12.20.2 Suzhou Best(CN) Business Overview

12.20.3 Suzhou Best(CN) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.20.4 Suzhou Best(CN) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.20.5 Suzhou Best(CN) Recent Developments

12.21 Anshan Beida(CN)

12.21.1 Anshan Beida(CN) Corporation Information

12.21.2 Anshan Beida(CN) Business Overview

12.21.3 Anshan Beida(CN) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.21.4 Anshan Beida(CN) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.21.5 Anshan Beida(CN) Recent Developments

12.22 Jiangxi Sanyuan(CN)

12.22.1 Jiangxi Sanyuan(CN) Corporation Information

12.22.2 Jiangxi Sanyuan(CN) Business Overview

12.22.3 Jiangxi Sanyuan(CN) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.22.4 Jiangxi Sanyuan(CN) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.22.5 Jiangxi Sanyuan(CN) Recent Developments

12.23 Yixing Hongbo(CN)

12.23.1 Yixing Hongbo(CN) Corporation Information

12.23.2 Yixing Hongbo(CN) Business Overview

12.23.3 Yixing Hongbo(CN) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.23.4 Yixing Hongbo(CN) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.23.5 Yixing Hongbo(CN) Recent Developments

12.24 Taixing Shenfeng(CN)

12.24.1 Taixing Shenfeng(CN) Corporation Information

12.24.2 Taixing Shenfeng(CN) Business Overview

12.24.3 Taixing Shenfeng(CN) 8-Hydroxyquinoline Product Models, Descriptions and Specifications

12.24.4 Taixing Shenfeng(CN) 8-Hydroxyquinoline Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.24.5 Taixing Shenfeng(CN) Recent Developments

muLu

13 Value Chain and Supply-Chain Analysis

13.1 8-Hydroxyquinoline Industry Chain

13.2 8-Hydroxyquinoline Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 8-Hydroxyquinoline Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 8-Hydroxyquinoline Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

muLu

14 8-Hydroxyquinoline Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

muLu

15 Key Findings in the Global 8-Hydroxyquinoline Study

muLu

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global 8-Hydroxyquinoline Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global 8-Hydroxyquinoline Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global 8-Hydroxyquinoline Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global 8-Hydroxyquinoline Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global 8-Hydroxyquinoline Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global 8-Hydroxyquinoline Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 7. Global 8-Hydroxyquinoline Sales by Region (2020-2025) & (K MT)
Table 8. Global 8-Hydroxyquinoline Sales by Region (2026-2031) & (K MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global 8-Hydroxyquinoline Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K MT)
Table 11. Global 8-Hydroxyquinoline Production by Region (2020-2025) & (K MT)
Table 12. Global 8-Hydroxyquinoline Production by Region (2026-2031) & (K MT)
Table 13. Global 8-Hydroxyquinoline Sales by Manufacturers (2020-2025) & (K MT)
Table 14. Global 8-Hydroxyquinoline Sales Share by Manufacturers (2020-2025)
Table 15. Global 8-Hydroxyquinoline Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global 8-Hydroxyquinoline Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global 8-Hydroxyquinoline by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 8-Hydroxyquinoline as of 2024)
Table 19. Global 8-Hydroxyquinoline Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global 8-Hydroxyquinoline Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers 8-Hydroxyquinoline Manufacturing Base and Headquarters
Table 22. Global 8-Hydroxyquinoline Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global 8-Hydroxyquinoline Sales by Type (2020-2025) & (K MT)
Table 26. Global 8-Hydroxyquinoline Sales by Type (2026-2031) & (K MT)
Table 27. Global 8-Hydroxyquinoline Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global 8-Hydroxyquinoline Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global 8-Hydroxyquinoline ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global 8-Hydroxyquinoline Sales by Application (2020-2025) & (K MT)
Table 32. Global 8-Hydroxyquinoline Sales by Application (2026-2031) & (K MT)
Table 33. 8-Hydroxyquinoline High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global 8-Hydroxyquinoline Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global 8-Hydroxyquinoline Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global 8-Hydroxyquinoline ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America 8-Hydroxyquinoline Growth Accelerators and Market Barriers
Table 40. North America 8-Hydroxyquinoline Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America 8-Hydroxyquinoline Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe 8-Hydroxyquinoline Growth Accelerators and Market Barriers
Table 43. Europe 8-Hydroxyquinoline Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe 8-Hydroxyquinoline Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific 8-Hydroxyquinoline Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific 8-Hydroxyquinoline Sales (K MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific 8-Hydroxyquinoline Growth Accelerators and Market Barriers
Table 48. Southeast Asia 8-Hydroxyquinoline Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America 8-Hydroxyquinoline Investment Opportunities and Key Challenges
Table 50. Central and South America 8-Hydroxyquinoline Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa 8-Hydroxyquinoline Investment Opportunities and Key Challenges
Table 52. Middle East and Africa 8-Hydroxyquinoline Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. 3M Company (US) Corporation Information
Table 54. 3M Company (US) Description and Major Businesses
Table 55. 3M Company (US) Product Models, Descriptions and Specifications
Table 56. 3M Company (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. 3M Company (US) Sales Value Proportion by Product in 2024
Table 58. 3M Company (US) Sales Value Proportion by Application in 2024
Table 59. 3M Company (US) Sales Value Proportion by Geographic Area in 2024
Table 60. 3M Company (US) 8-Hydroxyquinoline SWOT Analysis
Table 61. 3M Company (US) Recent Developments
Table 62. ABC Compounding Company (US) Corporation Information
Table 63. ABC Compounding Company (US) Description and Major Businesses
Table 64. ABC Compounding Company (US) Product Models, Descriptions and Specifications
Table 65. ABC Compounding Company (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. ABC Compounding Company (US) Sales Value Proportion by Product in 2024
Table 67. ABC Compounding Company (US) Sales Value Proportion by Application in 2024
Table 68. ABC Compounding Company (US) Sales Value Proportion by Geographic Area in 2024
Table 69. ABC Compounding Company (US) 8-Hydroxyquinoline SWOT Analysis
Table 70. ABC Compounding Company (US) Recent Developments
Table 71. Ecolab (US) Corporation Information
Table 72. Ecolab (US) Description and Major Businesses
Table 73. Ecolab (US) Product Models, Descriptions and Specifications
Table 74. Ecolab (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Ecolab (US) Sales Value Proportion by Product in 2024
Table 76. Ecolab (US) Sales Value Proportion by Application in 2024
Table 77. Ecolab (US) Sales Value Proportion by Geographic Area in 2024
Table 78. Ecolab (US) 8-Hydroxyquinoline SWOT Analysis
Table 79. Ecolab (US) Recent Developments
Table 80. DuPont (US) Corporation Information
Table 81. DuPont (US) Description and Major Businesses
Table 82. DuPont (US) Product Models, Descriptions and Specifications
Table 83. DuPont (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. DuPont (US) Sales Value Proportion by Product in 2024
Table 85. DuPont (US) Sales Value Proportion by Application in 2024
Table 86. DuPont (US) Sales Value Proportion by Geographic Area in 2024
Table 87. DuPont (US) 8-Hydroxyquinoline SWOT Analysis
Table 88. DuPont (US) Recent Developments
Table 89. Henkel (DE) Corporation Information
Table 90. Henkel (DE) Description and Major Businesses
Table 91. Henkel (DE) Product Models, Descriptions and Specifications
Table 92. Henkel (DE) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Henkel (DE) Sales Value Proportion by Product in 2024
Table 94. Henkel (DE) Sales Value Proportion by Application in 2024
Table 95. Henkel (DE) Sales Value Proportion by Geographic Area in 2024
Table 96. Henkel (DE) 8-Hydroxyquinoline SWOT Analysis
Table 97. Henkel (DE) Recent Developments
Table 98. Kao Corporation (JP) Corporation Information
Table 99. Kao Corporation (JP) Description and Major Businesses
Table 100. Kao Corporation (JP) Product Models, Descriptions and Specifications
Table 101. Kao Corporation (JP) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Kao Corporation (JP) Recent Developments
Table 103. Medical Chemical Corporation (US) Corporation Information
Table 104. Medical Chemical Corporation (US) Description and Major Businesses
Table 105. Medical Chemical Corporation (US) Product Models, Descriptions and Specifications
Table 106. Medical Chemical Corporation (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Medical Chemical Corporation (US) Recent Developments
Table 108. Metrex Research (US) Corporation Information
Table 109. Metrex Research (US) Description and Major Businesses
Table 110. Metrex Research (US) Product Models, Descriptions and Specifications
Table 111. Metrex Research (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Metrex Research (US) Recent Developments
Table 113. Prestige Brands (US) Corporation Information
Table 114. Prestige Brands (US) Description and Major Businesses
Table 115. Prestige Brands (US) Product Models, Descriptions and Specifications
Table 116. Prestige Brands (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Prestige Brands (US) Recent Developments
Table 118. P&G (US) Corporation Information
Table 119. P&G (US) Description and Major Businesses
Table 120. P&G (US) Product Models, Descriptions and Specifications
Table 121. P&G (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. P&G (US) Recent Developments
Table 123. RB Plc. (UK) Corporation Information
Table 124. RB Plc. (UK) Description and Major Businesses
Table 125. RB Plc. (UK) Product Models, Descriptions and Specifications
Table 126. RB Plc. (UK) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. RB Plc. (UK) Recent Developments
Table 128. SC Johnson & Son (US) Corporation Information
Table 129. SC Johnson & Son (US) Description and Major Businesses
Table 130. SC Johnson & Son (US) Product Models, Descriptions and Specifications
Table 131. SC Johnson & Son (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. SC Johnson & Son (US) Recent Developments
Table 133. Sealed Air Corporation (US) Corporation Information
Table 134. Sealed Air Corporation (US) Description and Major Businesses
Table 135. Sealed Air Corporation (US) Product Models, Descriptions and Specifications
Table 136. Sealed Air Corporation (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Sealed Air Corporation (US) Recent Developments
Table 138. Diversey (US) Corporation Information
Table 139. Diversey (US) Description and Major Businesses
Table 140. Diversey (US) Product Models, Descriptions and Specifications
Table 141. Diversey (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Diversey (US) Recent Developments
Table 143. Steris (US) Corporation Information
Table 144. Steris (US) Description and Major Businesses
Table 145. Steris (US) Product Models, Descriptions and Specifications
Table 146. Steris (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Steris (US) Recent Developments
Table 148. The Clorox Company (US) Corporation Information
Table 149. The Clorox Company (US) Description and Major Businesses
Table 150. The Clorox Company (US) Product Models, Descriptions and Specifications
Table 151. The Clorox Company (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. The Clorox Company (US) Recent Developments
Table 153. Unilever (UK) Corporation Information
Table 154. Unilever (UK) Description and Major Businesses
Table 155. Unilever (UK) Product Models, Descriptions and Specifications
Table 156. Unilever (UK) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Unilever (UK) Recent Developments
Table 158. Zep (US) Corporation Information
Table 159. Zep (US) Description and Major Businesses
Table 160. Zep (US) Product Models, Descriptions and Specifications
Table 161. Zep (US) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Zep (US) Recent Developments
Table 163. Zhejiang Huangyan Wanfeng(CN) Corporation Information
Table 164. Zhejiang Huangyan Wanfeng(CN) Description and Major Businesses
Table 165. Zhejiang Huangyan Wanfeng(CN) Product Models, Descriptions and Specifications
Table 166. Zhejiang Huangyan Wanfeng(CN) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Zhejiang Huangyan Wanfeng(CN) Recent Developments
Table 168. Suzhou Best(CN) Corporation Information
Table 169. Suzhou Best(CN) Description and Major Businesses
Table 170. Suzhou Best(CN) Product Models, Descriptions and Specifications
Table 171. Suzhou Best(CN) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Suzhou Best(CN) Recent Developments
Table 173. Anshan Beida(CN) Corporation Information
Table 174. Anshan Beida(CN) Description and Major Businesses
Table 175. Anshan Beida(CN) Product Models, Descriptions and Specifications
Table 176. Anshan Beida(CN) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Anshan Beida(CN) Recent Developments
Table 178. Jiangxi Sanyuan(CN) Corporation Information
Table 179. Jiangxi Sanyuan(CN) Description and Major Businesses
Table 180. Jiangxi Sanyuan(CN) Product Models, Descriptions and Specifications
Table 181. Jiangxi Sanyuan(CN) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Jiangxi Sanyuan(CN) Recent Developments
Table 183. Yixing Hongbo(CN) Corporation Information
Table 184. Yixing Hongbo(CN) Description and Major Businesses
Table 185. Yixing Hongbo(CN) Product Models, Descriptions and Specifications
Table 186. Yixing Hongbo(CN) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Yixing Hongbo(CN) Recent Developments
Table 188. Taixing Shenfeng(CN) Corporation Information
Table 189. Taixing Shenfeng(CN) Description and Major Businesses
Table 190. Taixing Shenfeng(CN) Product Models, Descriptions and Specifications
Table 191. Taixing Shenfeng(CN) Capacity, Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Taixing Shenfeng(CN) Recent Developments
Table 193. Key Raw Materials Distribution
Table 194. Raw Materials Key Suppliers
Table 195. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 196. Milestones in Production Technology Evolution
Table 197. Distributors List
Table 198. Market Trends and Market Evolution
Table 199. Market Drivers and Opportunities
Table 200. Market Challenges, Risks, and Restraints
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. 8-Hydroxyquinoline Product Picture
Figure 2. Global 8-Hydroxyquinoline Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Below 98% Product Picture
Figure 4. 98-99% Product Picture
Figure 5. 99-99.5% Product Picture
Figure 6. Above 99.5% Product Picture
Figure 7. Global 8-Hydroxyquinoline Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Medicine
Figure 9. Agriculture
Figure 10. Scientific
Figure 11. Others
Figure 12. 8-Hydroxyquinoline Report Years Considered
Figure 13. Global 8-Hydroxyquinoline Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 15. Global 8-Hydroxyquinoline Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global 8-Hydroxyquinoline Revenue Market Share by Region (2020-2031)
Figure 17. Global 8-Hydroxyquinoline Sales (2020-2031) & (K MT)
Figure 18. Global 8-Hydroxyquinoline Sales (CAGR) by Region (2020-2031) (K MT)
Figure 19. Global 8-Hydroxyquinoline Sales Market Share by Region (2020-2031)
Figure 20. Global 8-Hydroxyquinoline Capacity, Production and Utilization (2020-2031) & (K MT)
Figure 21. Global 8-Hydroxyquinoline Production Trend by Region (2020-2031) (K MT)
Figure 22. Global 8-Hydroxyquinoline Production Market Share by Region (2020-2031)
Figure 23. Production Capacity Enablers & Constraints
Figure 24. 8-Hydroxyquinoline Production Growth Rate in North America (2020-2031) & (K MT)
Figure 25. 8-Hydroxyquinoline Production Growth Rate in Europe (2020-2031) & (K MT)
Figure 26. 8-Hydroxyquinoline Production Growth Rate in China (2020-2031) & (K MT)
Figure 27. 8-Hydroxyquinoline Production Growth Rate in Japan (2020-2031) & (K MT)
Figure 28. Top 5 and Top 10 Manufacturers 8-Hydroxyquinoline Sales Volume Market Share in 2024
Figure 29. Global 8-Hydroxyquinoline Revenue Market Share Ranking (2024)
Figure 30. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 31. Below 98% Revenue Market Share by Manufacturer in 2024
Figure 32. 98-99% Revenue Market Share by Manufacturer in 2024
Figure 33. 99-99.5% Revenue Market Share by Manufacturer in 2024
Figure 34. Above 99.5% Revenue Market Share by Manufacturer in 2024
Figure 35. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 36. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 37. Global 8-Hydroxyquinoline Sales Market Share by Type (2020-2031)
Figure 38. Global 8-Hydroxyquinoline Revenue Market Share by Type (2020-2031)
Figure 39. Global 8-Hydroxyquinoline Sales Market Share by Application (2020-2031)
Figure 40. Global 8-Hydroxyquinoline Revenue Market Share by Application (2020-2031)
Figure 41. North America 8-Hydroxyquinoline Sales YoY (2020-2031) & (K MT)
Figure 42. North America 8-Hydroxyquinoline Revenue YoY (2020-2031) & (US$ Million)
Figure 43. North America Top 5 Manufacturers 8-Hydroxyquinoline Sales Revenue (US$ Million) in 2024
Figure 44. North America 8-Hydroxyquinoline Sales Volume (K MT) by Type (2020- 2031)
Figure 45. North America 8-Hydroxyquinoline Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 46. North America 8-Hydroxyquinoline Sales Volume (K MT) by Application (2020-2031)
Figure 47. North America 8-Hydroxyquinoline Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. US 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 49. Canada 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 50. Mexico 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 51. Europe 8-Hydroxyquinoline Sales YoY (2020-2031) & (K MT)
Figure 52. Europe 8-Hydroxyquinoline Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Europe Top 5 Manufacturers 8-Hydroxyquinoline Sales Revenue (US$ Million) in 2024
Figure 54. Europe 8-Hydroxyquinoline Sales Volume (K MT) by Type (2020-2031)
Figure 55. Europe 8-Hydroxyquinoline Sales Revenue (US$ Million) by Type (2020-2031)
Figure 56. Europe 8-Hydroxyquinoline Sales Volume (K MT) by Application (2020-2031)
Figure 57. Europe 8-Hydroxyquinoline Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Germany 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 59. France 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 60. U.K. 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 61. Italy 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 62. Russia 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 63. Asia-Pacific 8-Hydroxyquinoline Sales YoY (2020-2031) & (K MT)
Figure 64. Asia-Pacific 8-Hydroxyquinoline Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Asia-Pacific Top 8 Manufacturers 8-Hydroxyquinoline Sales Revenue (US$ Million) in 2024
Figure 66. Asia-Pacific 8-Hydroxyquinoline Sales Volume (K MT) by Type (2020- 2031)
Figure 67. Asia-Pacific 8-Hydroxyquinoline Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 68. Asia-Pacific 8-Hydroxyquinoline Sales Volume (K MT) by Application (2020-2031)
Figure 69. Asia-Pacific 8-Hydroxyquinoline Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Indonesia 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 71. Japan 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 72. South Korea 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 73. China Taiwan 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 74. India 8-Hydroxyquinoline Revenue (2020-2031) & (US$ Million)
Figure 75. Central and South America 8-Hydroxyquinoline Sales YoY (2020-2031) & (K MT)
Figure 76. Central and South America 8-Hydroxyquinoline Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Central and South America Top 5 Manufacturers 8-Hydroxyquinoline Sales Revenue (US$ Million) in 2024
Figure 78. Central and South America 8-Hydroxyquinoline Sales Volume (K MT) by Type (2021-2031)
Figure 79. Central and South America 8-Hydroxyquinoline Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Central and South America 8-Hydroxyquinoline Sales Volume (K MT) by Application (2020-2031)
Figure 81. Central and South America 8-Hydroxyquinoline Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. Brazil 8-Hydroxyquinoline Revenue (2020-2025) & (US$ Million)
Figure 83. Argentina 8-Hydroxyquinoline Revenue (2020-2025) & (US$ Million)
Figure 84. Middle East, and Africa 8-Hydroxyquinoline Sales YoY (2020-2031) & (K MT)
Figure 85. Middle East and Africa 8-Hydroxyquinoline Revenue YoY (2020-2031) & (US$ Million)
Figure 86. Middle East and Africa Top 5 Manufacturers 8-Hydroxyquinoline Sales Revenue (US$ Million) in 2024
Figure 87. Middle East and Africa 8-Hydroxyquinoline Sales Volume (K MT) by Type (2021-2031)
Figure 88. South America 8-Hydroxyquinoline Sales Revenue (US$ Million) by Type (2020-2031)
Figure 89. Middle East and Africa 8-Hydroxyquinoline Sales Volume (K MT) by Application (2020-2031)
Figure 90. Middle East and Africa 8-Hydroxyquinoline Sales Revenue (US$ Million) by Application (2020-2031)
Figure 91. GCC Countries 8-Hydroxyquinoline Revenue (2020-2025) & (US$ Million)
Figure 92. Turkey 8-Hydroxyquinoline Revenue (2020-2025) & (US$ Million)
Figure 93. Egypt 8-Hydroxyquinoline Revenue (2020-2025) & (US$ Million)
Figure 94. South Africa 8-Hydroxyquinoline Revenue (2020-2025) & (US$ Million)
Figure 95. 8-Hydroxyquinoline Industry Chain Mapping
Figure 96. Regional 8-Hydroxyquinoline Manufacturing Base Distribution (%)
Figure 97. 8-Hydroxyquinoline Production Process
Figure 98. Regional 8-Hydroxyquinoline Production Cost Structure
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global 8-Hydroxyquinoline market?zhanKai
The top companies in the global 8-Hydroxyquinoline market are 3M Company (US)、ABC Compounding Company (US)、Ecolab (US).
den_biaoTiZhungShi

Related Reports

Global 8-Hydroxyquinoline Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 182 Pages

Report ld: 5286216

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now